Meng Wu

1.5k total citations
71 papers, 922 citations indexed

About

Meng Wu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Meng Wu has authored 71 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 18 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Meng Wu's work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (10 papers) and Cancer-related Molecular Pathways (9 papers). Meng Wu is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (10 papers) and Cancer-related Molecular Pathways (9 papers). Meng Wu collaborates with scholars based in China, Portugal and United States. Meng Wu's co-authors include Yang Xu, Lili Yu, Weichao Wang, Yawei Huang, Shiguang Yang, Zhenfeng Ye, Xiaoqing Xi, Jun Li, Shuping Zhang and Xia Wan and has published in prestigious journals such as Cancer Cell, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Meng Wu

63 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meng Wu China	16	505	339	164	150	111	71	922
Jae Won Yun South Korea	15	353 0.7×	253 0.7×	201 1.2×	166 1.1×	93 0.8×	53	910
Carlo Capalbo Italy	22	838 1.7×	326 1.0×	386 2.4×	128 0.9×	85 0.8×	54	1.4k
Praveenkumar Shetty India	18	496 1.0×	181 0.5×	122 0.7×	122 0.8×	54 0.5×	58	847
Jianbo Tian China	20	830 1.6×	454 1.3×	199 1.2×	136 0.9×	168 1.5×	72	1.4k
Yixuan Yang China	20	598 1.2×	289 0.9×	253 1.5×	85 0.6×	169 1.5×	64	1.0k
Aoife Maguire Ireland	18	428 0.8×	203 0.6×	279 1.7×	112 0.7×	101 0.9×	34	1.0k
Mengyi Wang China	20	449 0.9×	180 0.5×	275 1.7×	103 0.7×	178 1.6×	77	1.1k
Qian Wu China	20	508 1.0×	285 0.8×	383 2.3×	179 1.2×	162 1.5×	81	1.1k
Hanchu Xiong China	17	746 1.5×	589 1.7×	148 0.9×	136 0.9×	97 0.9×	35	1.1k

Countries citing papers authored by Meng Wu

Since Specialization

Citations

This map shows the geographic impact of Meng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Wu more than expected).

Fields of papers citing papers by Meng Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Wu. The network helps show where Meng Wu may publish in the future.

Co-authorship network of co-authors of Meng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Wu. A scholar is included among the top collaborators of Meng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Wu. Meng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Meng, Xiaofang Chen, Haoran Wang, et al.. (2025). Discovery of the Clinical Candidate YY2201 as a Highly Potent and Selective ATR Inhibitor. Journal of Medicinal Chemistry. 68(5). 5292–5311. 4 indexed citations

Ma, Lin, Xianzhi Zhao, Tongtong Song, et al.. (2025). Identification of DNA Methylation Differences in Pituitary Tissues of Sichuan White Geese Using Whole-Genome Bisulfite Sequencing (WGBS). Biology. 14(2). 154–154.

Chen, Xin, Miaomiao Wang, Haoran Wang, et al.. (2024). METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor. Biomedicine & Pharmacotherapy. 179. 117366–117366. 7 indexed citations

Xu, Xin, Wei Zhao, Cuicui Liu, et al.. (2024). The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy. BMC Cancer. 24(1). 13–13. 9 indexed citations

Wu, Yaxian, et al.. (2024). A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients. Cancer Immunology Immunotherapy. 73(1). 14–14. 3 indexed citations

Wu, Yaxian, Shan Xing, Yu Wang, et al.. (2023). Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer. 11(8). e006552–e006552. 1 indexed citations

Yang, Yi, Cheng Cheng, Bin He, et al.. (2023). Cigarette smoking, by accelerating the cell cycle, promotes the progression of non-small cell lung cancer through an HIF-1α-METTL3-m6A/CDK2AP2 axis. Journal of Hazardous Materials. 455. 131556–131556. 22 indexed citations

Wu, Meng, et al.. (2023). The Development of p53-Targeted Therapies for Human Cancers. Cancers. 15(14). 3560–3560. 17 indexed citations

Li, Ying, Meng Wu, Lili Zhang, et al.. (2022). Nonsense-mediated mRNA decay inhibition synergizes with MDM2 inhibition to suppress TP53 wild-type cancer cells in p53 isoform-dependent manner. Cell Death Discovery. 8(1). 402–402. 7 indexed citations

10.

Liu, Jingchao, Zhipeng Zhang, Wei Zhang, et al.. (2022). Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer. Frontiers in Cell and Developmental Biology. 10. 791630–791630. 9 indexed citations

11.

Wu, Meng, Huimin Hou, Ying Li, et al.. (2022). Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer. Frontiers in Pharmacology. 13. 871259–871259. 5 indexed citations

12.

Ma, Yuhao, Jie Zeng, Lian C. T. Shoute, et al.. (2022). Improving immunoassay detection accuracy of anti-SARS-CoV-2 antibodies through dual modality validation. Biosensors and Bioelectronics X. 11. 100176–100176. 4 indexed citations

13.

Wu, Meng, et al.. (2022). Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study. Frontiers in Oncology. 12. 918137–918137. 2 indexed citations

14.

Qin, Xiaobing, Zhiyuan Xu, Meng Wu, et al.. (2022). Comparison of effectiveness and safety of camrelizumab between HBV-related and non-B, non-C hepatocellular carcinoma: A retrospective study in China. Frontiers in Genetics. 13. 1000448–1000448. 8 indexed citations

15.

Wu, Meng, Hui Gong, Kui Hu, et al.. (2020). Effect of syphilis infection on HIV acquisition: a systematic review and meta-analysis. Sexually Transmitted Infections. 97(7). 525–533. 72 indexed citations

16.

Ding, Jiwei, Meng Wu, Chen‐Chao Huang, et al.. (2019). Screening of kinase inhibitors downregulating PD-L1 expression via on/in cell quantitative immunoblots.. European Journal of Pharmaceutical Sciences. 142. 105088–105088. 10 indexed citations

17.

Guo, Liang, Yao Yao, Meng Wu, et al.. (2019). Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma. Scientific Reports. 9(1). 75–75. 30 indexed citations

18.

Lv, Kai, Shuo Wu, Wenyan Li, et al.. (2019). Design, synthesis and anti-HBV activity of NVR3-778 derivatives. Bioorganic Chemistry. 94. 103363–103363. 17 indexed citations

19.

Kim, Jinchul, Lili Yu, Wancheng Chen, et al.. (2019). Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation. Cancer Cell. 35(2). 191–203.e8. 144 indexed citations

20.

Tang, Jie, et al.. (2018). Diagnostic Performance of Multiparametric Transrectal Ultrasound in Localized Prostate Cancer: A Comparative Study With Magnetic Resonance Imaging. Journal of Ultrasound in Medicine. 38(7). 1823–1830. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact